Abstract:BACKGROUND:Major depressive disorder (MDD) is a global health challenge that impacts the quality of patients' lives severely. The disorder can manifest in many forms with different combinations of symptoms, which makes its clinical diagnosis difficult. Robust biomarkers are greatly needed to improve diagnosis and to understand the etiology of the disease. The main purpose of this study was to create a predictive model for MDD diagnosis based on peripheral blood transcriptomes.MATERIALS AND METHODS:We collected nine RNA expression datasets for MDD patients and healthy samples from the Gene Expression Omnibus database. After a series of quality control and heterogeneity tests, 302 samples from six studies were deemed suitable for the study. R package "MetaOmics" was applied for systematic meta-analysis of genome-wide expression data. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic effectiveness of individual genes. To obtain a better diagnostic model, we also adopted the support vector machine (SVM), random forest (RF), k-nearest neighbors (kNN), and naive Bayesian (NB) tools for modeling, with the RF method being used for feature selection.RESULTS:Our analysis revealed six differentially expressed genes (AKR1C3, ARG1, KLRB1, MAFG, TPST1, and WWC3) with a false discovery rate (FDR) < 0.05 between MDD patients and control subjects. We then evaluated the diagnostic ability of these genes individually. With single gene prediction, we achieved a corresponding area under the curve (AUC) value of 0.63 ± 0.04, 0.67 ± 0.07, 0.70 ± 0.11, 0.64 ± 0.08, 0.68 ± 0.07, and 0.62 ± 0.09, respectively, for these genes. Next, we constructed the classifiers of SVM, RF, kNN, and NB with an AUC of 0.84 ± 0.09, 0.81 ± 0.10, 0.73 ± 0.11, and 0.83 ± 0.09, respectively, in validation datasets, suggesting that the SVM classifier might be superior for constructing an MDD diagnostic model. The final SVM classifier including 70 feature genes was capable of distinguishing MDD samples from healthy controls and yielded an AUC of 0.78 in an independent dataset.CONCLUSION:This study provides new insights into potential biomarkers through meta-analysis of GEO data. Constructing different machine learning models based on these biomarkers could be a valuable approach for diagnosing MDD in clinical practice.

Artificial Intelligence-Based Major Depressive Disorder (MDD) Diagnosis Using Raman Spectroscopic Features of Plasma Exosomes

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Abnormal Expression Profile of Plasma-Derived Exosomal Micrornas in Patients with Treatment-Resistant Depression

Using Data-Driven Algorithms with Large-Scale Plasma Proteomic Data to Discover Novel Biomarkers for Diagnosing Depression

Using an Interpretable Amino Acid-Based Machine Learning Method to Enhance the Diagnosis of Major Depressive Disorder

Study on exosomes for identifying bipolar disorder in early stage: A cross-sectional and validation study protocol

Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data

Liquid Biopsy-Based Detection and Response Prediction for Depression

Identification of Diagnostic Markers for Major Depressive Disorder Using Machine Learning Methods

Surface-functionalized SERS platform for deep learning-assisted diagnosis of Alzheimer's disease

A Robust Deep-Learning Model to Detect Major Depressive Disorder Utilizing EEG Signals

Multiband EEG signature decoded using machine learning for predicting rTMS treatment response in major depression

A Preliminary Investigation on Plasma Cell Adhesion Molecules Levels by Protein Microarray Technology in Major Depressive Disorder

Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer's disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture

Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder

Serum proteomic analysis uncovers novel serum biomarkers for depression

Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection

Ensemble Learning for Early‐Response Prediction of Antidepressant Treatment in Major Depressive Disorder

Interpretable deep learning model for major depressive disorder assessment based on functional near-infrared spectroscopy

Automatic Depression Detection Using Smartphone-Based Text-Dependent Speech Signals: Deep Convolutional Neural Network Approach

EEG-based major depressive disorder recognition by selecting discriminative features via stochastic search